• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2010 年至 2019 年全球和地区范围内子宫肌瘤的发病率和患病率以及国家层面归因风险因素的趋势:全球数据库研究。

Global and regional trends in the incidence and prevalence of uterine fibroids and attributable risk factors at the national level from 2010 to 2019: A worldwide database study.

机构信息

Department of Obstetrics and Gynecology, State Key Laboratory of Complex, Severe and Rare Diseases, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

Center for Prevention and Early Intervention, National Infrastructures for Translational Medicine, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730.

出版信息

Chin Med J (Engl). 2024 Nov 5;137(21):2583-2589. doi: 10.1097/CM9.0000000000002971. Epub 2024 Feb 26.

DOI:10.1097/CM9.0000000000002971
PMID:38407293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11556989/
Abstract

BACKGROUND

Uterine fibroids (UFs), the most common tumors in women worldwide, may reduce quality of life and daily activities and even lead to adverse fertility and general health events in patients, causing significant societal health and financial burdens. The objective of this study was to evaluate the global burden through epidemiological trends and examine the potential risk factors for UFs at the national level.

METHODS

Data on the incidence, prevalence, disability-adjusted life years (DALYs), age-standardized incidence rates (ASIRs), age-standardized prevalence rates (ASPRs), and age-standardized DALY rates for UFs were collected, and the associations with the Human Development Index (HDI) and fertility were evaluated. The age trends in the average annual percent change (AAPC) of the incidence and prevalence rates of UFs were evaluated by joinpoint regression analysis. The associations between lifestyle, metabolic, and socioeconomic factors and the ASIRs of UFs were examined using multivariable linear regression analysis.

RESULTS

The worldwide incidence and prevalence of UFs have been increasing in the past decade, with AAPCs of 0.27% in the incidence rate and 0.078% in the prevalence rate. During 2010-2019, significant increasing trends in UF ASIR were observed in 52 of 88 countries. The age-specific incidence and prevalence of UFs in most age groups showed increasing trends except for 45-54-year-old women which showed no significant trend. Ecological analysis demonstrated no relationship between the incidence of UFs and the HDI but an inverse association with fertility. The incidence of UFs was positively correlated with alcohol intake, hypertension, overweight, and obesity and negatively correlated with smoking.

CONCLUSION

With the increasing incidence and prevalence worldwide, effective targeted prevention and control of relevant risk factors at the national level should be encouraged to reduce the disease burden of UFs.

摘要

背景

子宫肌瘤(UFs)是全球女性最常见的肿瘤,可能会降低生活质量和日常活动能力,甚至导致患者生育能力不良和整体健康状况恶化,给社会带来重大的健康和经济负担。本研究旨在通过流行病学趋势评估全球负担,并在国家层面探讨 UF 的潜在危险因素。

方法

收集 UF 的发病率、患病率、伤残调整生命年(DALYs)、年龄标准化发病率(ASIRs)、年龄标准化患病率(ASPRs)和年龄标准化 DALY 率数据,并评估与人类发展指数(HDI)和生育率的相关性。采用 Joinpoint 回归分析评估 UF 发病率和患病率的年均变化百分比(AAPC)的年龄趋势。采用多元线性回归分析评估生活方式、代谢和社会经济因素与 UF 的 ASIR 之间的关系。

结果

在过去十年中,全球 UF 的发病率和患病率呈上升趋势,发病率的 AAPC 为 0.27%,患病率的 AAPC 为 0.078%。2010-2019 年期间,88 个国家中有 52 个国家的 UF ASIR 呈显著上升趋势。除 45-54 岁女性外,大多数年龄组的 UF 年龄特异性发病率和患病率呈上升趋势,而该年龄组无明显趋势。生态分析表明,UF 的发病率与人类发展指数之间没有关系,但与生育率呈反比关系。UF 的发病率与饮酒、高血压、超重和肥胖呈正相关,与吸烟呈负相关。

结论

由于全球发病率和患病率的增加,应鼓励在国家层面采取有效的有针对性的预防和控制相关危险因素的措施,以减轻 UF 的疾病负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b2/11556989/49b927675310/cm9-137-2583-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b2/11556989/728aaba69925/cm9-137-2583-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b2/11556989/49b927675310/cm9-137-2583-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b2/11556989/728aaba69925/cm9-137-2583-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b2/11556989/49b927675310/cm9-137-2583-g002.jpg

相似文献

1
Global and regional trends in the incidence and prevalence of uterine fibroids and attributable risk factors at the national level from 2010 to 2019: A worldwide database study.2010 年至 2019 年全球和地区范围内子宫肌瘤的发病率和患病率以及国家层面归因风险因素的趋势:全球数据库研究。
Chin Med J (Engl). 2024 Nov 5;137(21):2583-2589. doi: 10.1097/CM9.0000000000002971. Epub 2024 Feb 26.
2
The global burden of polycystic ovary syndrome, endometriosis, uterine fibroids, cervical cancer, uterine cancer, and ovarian cancer from 1990 to 2021.1990年至2021年多囊卵巢综合征、子宫内膜异位症、子宫肌瘤、宫颈癌、子宫癌和卵巢癌的全球负担。
BMC Public Health. 2025 May 14;25(1):1774. doi: 10.1186/s12889-025-22881-3.
3
Burden of uterine cancer in China from 1990 to 2021 and 15-year projection: a systematic analysis and comparison with global levels.中国 1990 年至 2021 年以及 15 年预测的子宫癌负担:系统分析与全球水平的比较。
Reprod Health. 2024 Oct 10;21(1):144. doi: 10.1186/s12978-024-01882-2.
4
Global trends and regional differences in disease burden of stroke among children: a trend analysis based on the global burden of disease study 2019.全球儿童卒中疾病负担的趋势和区域差异:基于 2019 年全球疾病负担研究的趋势分析。
BMC Public Health. 2023 Oct 27;23(1):2120. doi: 10.1186/s12889-023-17046-z.
5
Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990-2019: an age-period-cohort analysis for the global burden of disease 2019 study.全球、地区和国家子宫纤维瘤发病率、患病率和残疾生存年数的时间趋势,1990-2019 年:对 2019 年全球疾病负担研究的年龄-时期-队列分析。
BMC Public Health. 2023 May 19;23(1):916. doi: 10.1186/s12889-023-15765-x.
6
Global and China trends and forecasts of disease burden for female lung Cancer from 1990 to 2021: a study based on the global burden of disease 2021 database.1990年至2021年全球及中国女性肺癌疾病负担的趋势与预测:一项基于2021年全球疾病负担数据库的研究
J Cancer Res Clin Oncol. 2025 Feb 8;151(2):68. doi: 10.1007/s00432-025-06084-2.
7
Global, regional and national burdens of acne vulgaris in adolescents and young adults aged 10-24 years from 1990 to 2021: a trend analysis.1990年至2021年10至24岁青少年和青年寻常痤疮的全球、区域和国家负担:一项趋势分析
Br J Dermatol. 2025 Jan 24;192(2):228-237. doi: 10.1093/bjd/ljae352.
8
Global, regional, and national burden of uterine fibroids in the last 30 years: Estimates from the 1990 to 2019 Global Burden of Disease Study.过去30年全球、区域和国家子宫肌瘤负担:1990年至2019年全球疾病负担研究的估计数。
Front Med (Lausanne). 2022 Nov 7;9:1003605. doi: 10.3389/fmed.2022.1003605. eCollection 2022.
9
Global Trends of Early, Middle, and Late-Onset Lung Cancer From 1990 to 2021: Results From the Global Burden of Disease Study 2021.1990年至2021年全球早发、中发和晚发肺癌的趋势:2021年全球疾病负担研究结果
Cancer Med. 2025 Feb;14(3):e70639. doi: 10.1002/cam4.70639.
10
Temporal trends of thyroid cancer in China and globally from 1990 to 2021: an analysis of the global burden of Disease Study 2021.中国和全球甲状腺癌的时间趋势:2021 年全球疾病负担研究分析。
Sci Rep. 2024 Oct 26;14(1):25538. doi: 10.1038/s41598-024-77663-5.

引用本文的文献

1
The stem bark decoction of Myrianthus arboreus P. Beauv. (Cecropiaceae) shows anti-uterine leiomyoma effects in Wistar rat.乔木桑科植物多蕊桑(Myrianthus arboreus P. Beauv.)的茎皮煎剂对Wistar大鼠显示出抗子宫肌瘤的作用。
Reprod Fertil. 2025 Jul 26;6(3). doi: 10.1530/RAF-25-0037. Print 2025 Jul 1.

本文引用的文献

1
National trends and determinants of hospitalization for uterine leiomyomas - Portuguese public database analysis from 2000 to 2015.子宫平滑肌瘤住院治疗的全国趋势及决定因素——2000年至2015年葡萄牙公共数据库分析
Eur J Obstet Gynecol Reprod Biol. 2020 Dec;255:231-236. doi: 10.1016/j.ejogrb.2020.10.043. Epub 2020 Oct 20.
2
Alcohol Consumption and Risk of Uterine Fibroids.饮酒与子宫肌瘤风险的关系。
Curr Mol Med. 2020;20(4):247-258. doi: 10.2174/1566524019666191014170912.
3
A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014.
一项基于美国人群的子宫肌瘤诊断发病率、趋势和流行率的研究:2005 年至 2014 年。
Am J Obstet Gynecol. 2018 Dec;219(6):591.e1-591.e8. doi: 10.1016/j.ajog.2018.09.039. Epub 2018 Oct 3.
4
Uterine Fibroids: Burden and Unmet Medical Need.子宫肌瘤:负担与未满足的医疗需求
Semin Reprod Med. 2017 Nov;35(6):473-480. doi: 10.1055/s-0037-1607264. Epub 2017 Nov 3.
5
Epidemiology of uterine fibroids: a systematic review.子宫肌瘤的流行病学:系统评价。
BJOG. 2017 Sep;124(10):1501-1512. doi: 10.1111/1471-0528.14640. Epub 2017 May 13.
6
Uterine fibroid management: from the present to the future.子宫肌瘤的管理:从现在到未来。
Hum Reprod Update. 2016 Nov;22(6):665-686. doi: 10.1093/humupd/dmw023. Epub 2016 Jul 27.
7
Epidemiology of Uterine Fibroids: From Menarche to Menopause.子宫肌瘤的流行病学:从初潮到绝经
Clin Obstet Gynecol. 2016 Mar;59(1):2-24. doi: 10.1097/GRF.0000000000000164.
8
Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.子宫平滑肌瘤发生和生长所涉及分子机制的流行病学及遗传学线索
Hum Reprod Update. 2015 Sep-Oct;21(5):593-615. doi: 10.1093/humupd/dmv030. Epub 2015 Jul 3.
9
Uterine fibroids.子宫肌瘤
N Engl J Med. 2013 Oct 3;369(14):1344-55. doi: 10.1056/NEJMra1209993.
10
The estimated annual cost of uterine leiomyomata in the United States.估计美国子宫平滑肌瘤的年度成本。
Am J Obstet Gynecol. 2012 Mar;206(3):211.e1-9. doi: 10.1016/j.ajog.2011.12.002. Epub 2011 Dec 11.